[PTGX] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
30-Mar-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -113.85%
YoY- -335.56%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 6,189 3,647 1,560 10,781 0 0 0 -
PBT -23,998 -19,904 -13,920 -7,661 -14,101 -11,747 -2,697 43.90%
Tax -79 176 183 0 0 4,707 8 -
NP -23,998 -20,080 -14,103 -7,661 -14,101 -11,747 -2,697 43.90%
Tax Rate - - - - - - - -
Total Cost 30,187 23,727 15,663 18,442 14,101 11,747 2,697 49.50%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -387.75 -550.59 -904.04 -71.06 0.00 0.00 0.00 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.54 -0.72 -0.58 -0.36 -0.84 -2.00 -0.46 2.70%
EPS Diluted -0.54 -0.72 -0.58 -0.36 -0.84 -2.00 -0.46 2.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.